ECPG vs TMO · P/E 6.3, rev $1.32B vs P/E 24, rev $44.56B
Encore Capital Group Inc (ECPG) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Encore Capital Group Inc (ECPG) is a credit services company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported ECPG revenue for 2024-12-31 was $1.32B. Net income was -$139.2M. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. ECPG currently screens at market cap $1.73B and trailing P/E 6.3.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
ECPG currently screens at market cap $1.73B and trailing P/E 6.3. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the ECPG and TMO stock pages for the full models.
Not investment advice.